SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-16-012123
Filing Date
2016-04-12
Accepted
2016-04-12 16:03:45
Documents
7
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2227896z20-f.htm 20-F 2116958
2 EX-1.1 a2227896zex-1_1.htm EX-1.1 1915878
3 EX-12.1 a2227896zex-12_1.htm EX-12.1 11062
4 EX-12.2 a2227896zex-12_2.htm EX-12.2 10987
5 EX-13.1 a2227896zex-13_1.htm EX-13.1 6076
6 EX-13.2 a2227896zex-13_2.htm EX-13.2 6065
7 EX-23.1 a2227896zex-23_1.htm EX-23.1 3340
  Complete submission text file 0001047469-16-012123.txt   4071331
Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100
Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 161567294
SIC: 2834 Pharmaceutical Preparations